125
Participants
Start Date
June 19, 2024
Primary Completion Date
September 9, 2025
Study Completion Date
September 9, 2025
Obsidio™ Conformable Embolic
Embolization with Obsidio™ Conformable Embolic.
Mount Sinai Medical Center, New York
Albany Medical Center, Albany
Christiana Hospital, Newark
MedStar Georgetown University Hospital, Washington D.C.
University of North Carolina Hospital, Chapel Hill
Emory University Hospital, Atlanta
Mercy Hospital, Coon Rapids
Northwestern Memorial Hospital, Chicago
University of Chicago Hospital, Chicago
Barnes Jewish Hosital, St Louis
University of Kansas Hospital, Kansas City
The University of Texas MD Anderson Cancer Center, Houston
University of Texas Houston Health Science Center, Houston
Mayo Clinic Hospital, Phoenix
Ronald Reagan UCLA Medical Center, Los Angeles
St. Joseph's Medical Center, Stockton
University of Washington Medical Center, Seattle
Massachusetts General Hospital, Boston
Beth Israel Deaconess Medical Center, Boston
University Hospital, Newark
Lead Sponsor
Boston Scientific Corporation
INDUSTRY